Nuclear medicine vendor ADAC Laboratories will highlight its MolecularCoincidence Detection (MCD) technique, which enables high-energypositron imaging to be conducted on gamma cameras without theuse of the heavy collimators employed in 511-KeV imaging.
Nuclear medicine vendor ADAC Laboratories will highlight its MolecularCoincidence Detection (MCD) technique, which enables high-energypositron imaging to be conducted on gamma cameras without theuse of the heavy collimators employed in 511-KeV imaging.
ADAC, of Milpitas, CA, debuted MCD at the Society of NuclearMedicine meeting in Minneapolis earlier this year (SCAN 6/21/95).By employing the digital architecture of ADAC's Epic technology,MCD uses electronic collimation to measure coincidents, whichoccur when photons are released at 180° angles due to theannihilation of an electron by a positron. MCD achieves an intrinsicresolution of 4 mm, compared to about 10-mm resolution in 511-KeVimaging. ADAC is awaiting 510(k) clearance for the technique.
ADAC's Solus and Cardio gamma cameras will also make their RSNAdebut. Introduced at the SNM meeting, Solus is a fixed-angle 180°dual-head camera, while Cardio is a 90° dual-head for dedicatedcardiac imaging. The new products are designed to target specificapplications at a lower price point than ADAC's premium Vertexcamera.
The third part of ADAC's new product triangle is Vantage, thevendor's attenuation-correction protocol for cardiac imaging,which received Food and Drug Administration clearance in April(SCAN 5/10/95).
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.